MedPath

A human study to evaluate of efficacy and safety of EFR on immune functio

Not Applicable
Completed
Conditions
Factors influencing health status and contact with health services
Registration Number
KCT0006255
Lead Sponsor
Bundang Jesaeng Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

1) Subject who voluntarily agrees to participate and signs in informed consent form
2) Healthy people, 20 = age < 70.
3) Stress self assessment scaled above strong
4) Subjects suffered from upper respiratory track infection or cold-related symptoms which have possibilities to
cause upper respiratory track infection more than two times in the past one year.
5) White blood cell(WBC) ranged normal”

Exclusion Criteria

1) Patients who was diagnosed and are currently in the treatment of diabetes
2) Subjects who are currently in the treatment of significant clinical disease related to acute or chronic cardiovascular system, immune system, respiratory system, liver biliary, kidney and urinary tract, nervous system, musculoskeletal disorders, psychic, infection and blood neoplastic.
3) Subjects who have medical history with myocardial infarction or cerebrovascular disease within 6 months.
4) Subjects who have a neurologically or psychologically important medial history or who is currently suffering from a disease.
5) Subjects who have uncontrolled high blood pressure.
6) Subjects whose AST or ALT exceeds 3 times of normal range.
7) Subjects whose creatinine exceeds 2 times of normal range.
8) Subjects who have complained of severe gastrointestinal symptoms such as heartburn, indigestion.
9) Subjects who got a vaccination within 1 months before screening.
10) Excessive smoker
11) Subjects who usually consume alcohol as follows - men: 210g/week, women 140g/week
12) Subjects whose BMI is under 18.5 or exceeds 30.0
13) Subjects who continue to consume beta-glucan or rice bran-containing food within one month of their first visit
14) Subjects who have intaken or is intaking functional foods
15) Subjects who are planning to participate other studies within one month of their first visit
16) Subjects who are pregnant or breastfeeding or planning a pregnancy.
17) Subjects who are sensitive to test foods/algae or have food allergies.
18) Subjects who are deemed to be inappropriate to this study.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
K cell activity (%) et al.
Secondary Outcome Measures
NameTimeMethod
Adverse events et al.
© Copyright 2025. All Rights Reserved by MedPath